HIV Prevention

A randomized trial evaluated whether the 4CMenB vaccine prevents gonorrhea among adults at high risk for infection.

A US prescription claims study evaluated uptake and 2-year persistence among users of long-acting injectable cabotegravir for HIV PrEP.

Improving TDF-FTC uptake among US young men who have sex with men on HIV PrEP could yield substantial 10-year value, while a hypothetical study eliminating adverse event uncertainty would not change the...

In a phase 3b trial, monthly dapivirine ring and daily oral PrEP were assessed for safety, adherence, and acceptability in pregnancy.

A type III hybrid effectiveness–implementation trial compared community-based organization versus direct-to-consumer delivery of the Keep It Up! digital HIV prevention intervention for young men who have...

A large US cohort study evaluated the scale, patient characteristics, and retention outcomes of telemedicine-delivered HIV preexposure prophylaxis (PrEP), offering clinicians new data on how telePrEP is...

Start fast, suppress durably, and think beyond the viral load: this primary care–focused guide covers diagnosis, same-day antiretroviral therapy, monitoring, opportunistic infection prevention, vaccines,...

A pilot randomized trial found that offering immediate pre-exposure prophylaxis (PrEP) initiation with a 28-day starter pack in the emergency department did not improve PrEP use or retention compared with...

In a recent multicenter retrospective case series, isotretinoin was effective in treating acne among transgender and gender-diverse individuals undergoing masculinizing hormone therapy, with significantly...

Sexual and gender minority (SGM) populations face significantly higher odds of being diagnosed with multiple mental health conditions compared with their cisgender heterosexual counterparts, according to a...